A method for kinetic analysis of dynamic pos itron emission tomography (PET) data by linear program ming that allows identification of the components of a measured PET signal without predefining a compartmen tal model has recently been proposed by Cunningham and co-workers . The method identifies a small subset of func tions from a large input set of feasible functions that best fits the time course of total radioactivity measured by PET . To investigate in detail the properties of this tech nique, we applied it to PET studies with [18Flfluorode oxyglucose, a tracer with well-characterized kinetic prop erties. We examined dynamically acquired data over var ious time intervals in many brain regions and found that the number of components identified by the method is stable and consistent with the presence of kinetic hetero geneity in every region. We optimized the method for Two main approaches are currently used for the analysis of data acquired by positron emission to mography (PET): compartmental modeling and the multiple-time graphical analysis technique (Gjedde, 1982; Patlak et ai., 1983; Patlak and Blasberg, 1985) . Procedures based on compartmental modeling rely
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on the a priori formulation of a description of the biochemical or physiological system under study, i.e., a kinetic model, and on nonlinear least-squares algorithms to estimate the parameters of the model from the time courses of radioactivity measured in selected tissue regions of interest. Of necessity, ki netic models thus formulated are simplified descrip tions of the complex processes occurring in vivo, and the effects of such simplifications must be taken into account when assessing the final results of any study. For example, most kinetic models assume that the tissue region examined is homogeneous with respect to rates of blood flow, metabolism, receptor binding, etc., a condition that is rarely, if ever, achieved with PET. An alternative to the use of compartmental models is the multiple-time graphical analysis technique to evaluate unidirec-tional uptake of tracer from the time course of total tissue radioactivity. This technique has the advan tage that it applies to heterogeneous as well as ho mogeneous tissues (Mori et al. , 1990) , but it re quires the identification of both a lower time limit when all tissue pools have equilibrated with the ar terial plasma and an upper time limit before signif icant product loss occurs.
Recently, co-workers (1991, 1992; Cunningham and Jones, 1993) introduced a new technique to identify the components in PET tissue radioactivity data with no prior assumptions of a specific kinetic model and no assumptions about tissue equilibration or product loss. Because the technique provides a spectrum of the kinetic components in the data, it has been called "spectral analysis. " Spectral analysis shares with the multi ple-time graphical analysis its applicability to het erogeneous as well as homogeneous tissues and is also applicable to a wide range of tracer compounds (Cunningham and Jones, 1993) . The purpose of the current study was to investigate in detail the prop erties of the spectral analysis technique. Since the kinetic components of eSF]fluorodeoxyglucose ([lsF]FDG) have been well described previously with conventional compartmental analyses, both in homogeneous tissue Reivich et al. , 1979; Huang et al. , 1980) and in heterogeneous tissues , we chose eSF]FDG as the tracer compound for our examination of the properties of the spectral analysis technique.
THEORETICAL BASIS OF SPECTRAL ANALYSIS TECHNIQUE: RELATIONSHIP TO COMPARTMENTAL MODELS OF THE FDGMETHOD
The spectral analysis technique employs linear programming methods to provide estimates of the nonnegative coefficients A�l' Ao, AI' A2, •.. , An' such that the total radioactivity measured by the PET scanner, (7* total, at any time T can be de scribed as n + � A j[ J O T q(t)exp[ -i3iTt)]dt] (1) where C;(t) represents the concentration of the ra dioactive precursor molecule in the arterial plasma or blood compartment (Cunningham et al. , 1991 (Cunningham et al. , , 1992 Cunningham and Jones, 1993) . Input to the program consists of total radioactivity measured by the PET scanner in a region of interest at m time points, T 1 , T2, ••• , T m> and the time course of measured plasma or blood radioactivity. A large number of positive values that are candidates to be used as exponents of the equilibrating components, i3i, is set a priori. A simplex algorithm (Press et al. , 1986 ) is used to select a subset of n of these values and to determine the corresponding positive coeffi cients, Ai' such that the sum of the absolute value of the difference between the total radioactivity mea sured at each time point and the radioactivity esti mated by Eq. (1) is minimized. In other words, the program minimizes the value of m (2) ;= 1 where r; is the residual difference between the mea sured and the estimated total radioactivities at the ith time of measurement. r; is given by
Linear programming methods minimize linear func tions of the independent variables subject to linear constraints (see, e.g. , Danzig, 1963) . In this case, the function to be minimized [Eq.
(2)] is not linear in the variables to be estimated, i.e. , in the coeffi cients A � 1 , Ao, AI' A2, •.. , An' but as described by Cunningham and Jones (1993) , the problem can be transformed into a linear programming problem through the introduction of "error variables." It is important to note that, even though there are a large number of coefficients to be estimated, at most m of them can be nonzero (Press et al. , 1986) . In general, there exist either zero solutions, one unique solu tion, or an infinite number of solutions to the linear programming problem (Danzig, 1963) .
The relationship of the parameters found with the spectral analysis technique to those derived from conventional compartmental analyses of eSF]FDG data measured in heterogeneous tissues is described below.
Kinetics of [ ls F]FDG in heterogeneous tissue
Following the intravenous injection of [ ls F]FDG, the kinetic behavior of the tracer in brain can be described by a two-compartment model provided that the region of interest consists of a tissue that is homogeneous with respect to rates of blood flow, transport of hexoses across the blood-brain barrier, glucose metabolism, eSF]FDG phosphorylation, and concentrations of eSF]FDG, glucose, and [lsF]fluorodeoxyglucose-6-phosphate ([lsF]FDG-6-P) (Sokoloff et aI., 1977; Reivich et aI., 1979) . If the period of measurement is kept within 120 min fol lowing injection of the tracer, a period of time dur ing which there is no evidence for significant loss of eSF]FDG-6-P (Schmidt et aI., 1992) , the following equations describe the rate of change in the concen trations of eSF]FDG and eSF]FDG-6-P in the ho mogeneous tissue:
where C:(t) represents the concentration of eSF]FDG in the brain tissue at any time t; Cri;(t) represents the concentration of [lsF]FDG-6-P (and all metabolites derived from eSF]FDG-6-P) in the same region; Ki and kf are the rate constants for transport of eS]FDG from plasma to brain and from brain to plasma, respectively; kj is the rate constant for phosphorylation of eSF]FDG in the tissue; and C;(t) represents the eSF]FDG concentration in the arterial plasma. A schematic representation of the model is presented in Fig. 1A . Solution of Eqs. (4) and (5), with the initial conditions that C:(O) = Cri;(O) = 0, shows that
and
The total tissue radioactivity, C*(1), is the sum of the free eSF]FDG concentration plus the concen tration of metabolites, i.e., C*(1) = C:(1) + C�(1)
Substituting Eqs. (6) and (7) into Eq. (8) and adding the two integrals that have the same exponent (kf + kj) yields (9) Equation (9) provides an alternate mathematical de scription of the tissue as one comprised of two com partments directly connected to the plasma pool ( Fig. lB) . Following a pulse of eSF]FDG, the sec ond term in Eq. (9) declines toward zero with time Components neous tissue represented as a col lection of n homogeneous subregions. Each homogeneous subregion is model ed as two compartments connected in series 19 the plasma pool as in A; hence there is a total of 2n compartments. The tissue concen tration measured by the scanner, C*, is the weighted-average concentration of radioactivity in each of the subregions. (0)
Mathematical ly equival ent description of the heterogeneous tissue as one comprised of (n + 1) compartments in paral lel, each directly connected to the plasma pool . The "integrated component" is the weighted sum of the "integrated components" of the homogeneous subregions. There are n "equilibrating components, " one for each homogeneous subregion of the mixed tissue.
as the tissue tends toward equilibration with the arterial plasma; hence we label this term the "equil ibrating component." The first term in Eq. (9) is the integrated activity of the arterial plasma eSF]FDG concentration; hence we call it the "integrated com ponent. "
With the limited spatial resolution of the PET scanner, however, measurement of radioactivity in a homogeneous tissue is rarely, if ever, achieved. Instead, the radioactivity measured in any region of interest originates from a heterogeneous collection of tissues within the field of view, each with its own rates of blood flow and metabolism; it includes as well some spillover radioactivity originating from surrounding tissues. The tissue concentration mea sured by the scanner represents the mass-weighted average concentration of radioactivity in each of the tissues included in the region (Fig. lC) . The math ematical model and Eq. (9) apply to each of the homogeneous subregions of the mixed tissue, i.e., the tissue radioactivities in subregions a, b, ... of the mixed tissue are given by:
If there are n kinetically distinct tissues, then the weighted average radioactivity in the mixed tissue as a whole, C*(n, is found by summing the activ ities in each subregion weighted by its relative tis sue mass. If the relative mass weights of the tissues are Wa, Wb' ... , Wn, where Wa + Wb + ... + Wn = 1, then c*(n = Wa C:(n + Wb Cti(n + ...
The 2n-compartment model of Eq. (10) is, there fore, mathematically equivalent to the (n + 1) compartment model of Eq. (11) ( Fig. ID) . Finally, the radioactivity measured by the PET scanner in cludes the radioactivity in the cerebral blood, i.e.,
Ci ota
where Ciota l (n is the total radioactivity measured by the scanner at time T; [wblood/Wtotaa and [Wt issue / Wtotaa are the fractions of the region of interest com prised of blood and tissue, respectively; C�ood(n is the concentration of radioactivity in the cerebral blood at time T; and c * (n is the weighted average concentration of radioactivity in the extravascular mixed tissue as described in Eq. (8). If the region is comprised only of tissue and blood, then and
where rCBV is the regional cerebral blood volume. Equations (11) through (14) can be combined, and the total radioactivity measured by the PET scanner at time T can be written as
where A_I is related to the blood volume by
and the coefficients and exponents of the equilibrat ing components, Aj and !3j, respectively, are
In humans, the FDG in the red cells and in the plasma is usually assumed to be in rapid equilibrium (Phelps et aI., 1979) ; hence C b/oo,/ T)/Cp*(T) is con stant with time and its value dependent upon the equilibrium distribution ratio of FDG between ezythzocytes and plasma and the hematocrite in the cerebral vessels.
Gl ucose utilization
The rate of glucose utilization in the jth homoge neous subregion of the mixed tissue is given by (Huang et aI., 1, 980) (19) where Cp is the plasma glucose concentration and LC is the lumped constant. In a heterogeneous tis sue region of interest, the weighted-average rate of regional cerebral glucose utilization, rCMRglc, is equal to the weighted sum of the rates of glucose utilization in each of the homogeneous subregions as follows:
Combining Eqs. (16), (17), and (20) establishes the relationship between the coefficient of the arterial plasma term (A _ I), the coefficient of the integrated component (Ao), and the weighted-average glucose utilization as follows:
In the case when glucose utilization is expressed per total weight of both the tissue and its blood content, Eq. (21) reduces to
MATERIALS AND METHODS
Implementation of the spectral analysis technique and simulation studies
Factors that determine the components that can be de tected by spectral analysis include the schedule for mea suring the radioactivity concentrations in the tissue, the noise in the measured data, the number of exponents used blood compartment and two tissue compartments with well-separated, but reasonable, exponents, i.e., I3j = 0.5 min -I for gray matter and I3j = 0.05 min -1 for white matter . The ratios of gray/white tissue weights used were 4: 1, 1: 1, or \ :4. Normally distributed zero-mean random noise was added to the stimulated total radioactivity, and the spectral analysis program executed 1,000 times. For each exponent 131' the number of times that the program identified a component with that exponent was counted . The fraction of times that a component with a particular exponent was found by the spectral analysis program was taken as an approximation of the probability of identifi cation of that component . Simulations were performed with two noise levels encountered in actual PET [18F]FDG data: high noise, based on the counts found in each time interval following injection of tracer in a small white matter region (standard deviation varying from �40% in the first frame of data to �9% during peak counting rates) ; and low noise, based on total counts in a whole image plane (standard deviation varying from �9% in the first frame of data to � 2% during peak counting rates) . The frequency below which the components were indistinguishable from the integrated plasma activity was considered to be that frequency between 0 and 0.05 min -I where the fewest components were detected, i.e., the "trough" between the observed distributions around the integrated plasma activity and the simulated white matter component. Similarly, the frequency above which components were indistinguishable from the blood com partment itself was considered to be that frequency be tween 0.5 min -1 and the upper limit tested where the fewest components were detected, i.e., the trough be tween the high-frequency noise and the distribution of the simulated gray matter component . Several distributions for the exponents I3j were examined, including linear, quadratic, logarithmic, and a distribution suggested by DiStefano (1981) for choosing an initial sampling schedule to identify unknown components in a measured signal. The distribution suggested by DiStefano is given by
where T I is the fastest time constant of the distribution, Tk is the slowest time constant of the distribution, and k is the number of the points in the distribution. Since the purpose of [18FlFDG studies is the determination of the rate of glucose utilization, a distribution was chosen that produced the most stable estimates of the coefficient Ao, the value upon which the equation for glucose utilization depends most heavily [Eqs.
( 2 1) and (22)] . Numerical filtering. Noise in the total radioactivity data leads to a significant probability of detecting very slow components (i.e., those with low values for the ex ponent 13) even when there is none actually present in the tissue . In this situation, the spectral analysis technique may give an inaccurate estimate of the coefficient Ao and, hence, of the estimate of the glucose utilization rate. We investigated several methods to correct this problem, all of which required the determination of a lower cutoff fre quency, I3cutoff ' for the exponents. The first method, as suggested by Cunningham and Jones (1993) , was to add to Ao the coefficients of all identified components with ex ponents less than the cutoff frequency. The second method was to eliminate all exponents less than the cutoff frequency from the set of I3j input to the spectral analysis program. The third method was the application of a sim ple numerical filter in which all identified components with exponents greater than zero but less than I3cutoff were assumed to be due to noise in the data, and the remaining components with exponents greater than I3cutoff were assumed to correspond to real equilibrating pro cesses in the system. To compute Ao with this method, the blood component and all identified equilibrating com ponents whose exponents were higher than I3cutoff were subtracted from the total radioactivity data to obtain the integrated component, Ao rr;C�(t)dt, plus noise. A linear least-squares procedure was then used to estimate Ao as the slope of the graph of the integrated component versus J{; C�(t)dt.
PET studies
We reexamined the data acquired from [18F]FDG PET scans of three normal male subjects (aged 26, 27, and 39 years) whose studies have been described previously (Lu cignani et aI ., \993) . Briefly, scans were performed with a four-ring whole-body PET (Model 931/04-12; Siemens/ CPS, Knoxville, TN, U.S.A.). Subjects were positioned on the scanner bed with their heads immobilized by a customized head holder, and a lO-min transmission scan was carried out with an external 68Ge ring source. Each subject then received an intravenous pulse of approxi mately 7-10 mCi of [18F]FDG synthesized according to the method of Hamacher et al . (1986) . Simultaneous ac quisition of data from seven equally spaced transaxial planes (four direct and three cross planes ; slice thickness, 6.75 mm) parallel to the orbital-meatal line covering an axial field of view of 5.4 cm was carried out . Scanning proceeded sequentially according to the following sched ule: 5 scans of 1 min each, 5 scans of 2 min each, and 21 scans of 5 min each, for a total scanning time of 120 min. Timed blood samples were collected from a radial arterial line continuously for the first minute following [18F]FDG administration and then at increasing intervals up to the end of PET scanning ; they were rapidly centrifuged, and glucose and 18F concentrations assayed in the plasma . Scans were reconstructed with a Hann filter with a cutoff frequency of 0.5 cycles/pixel, and each image was recon structed on a 128 x 128 matrix with a pixel size of 1.56 mm . Correction for attenuation of the 511-KeV annihila tion 'I-rays by the tissue was performed with the coeffi cients obtained from the transmission scan, and all data were corrected for radioactive decay. Thirty-one discrete anatomical regions of interest (ROIs), according to the atlas of Damasio and Damasio (1989) , were drawn on the image from the final emission scan (Fig. 2) and then trans ferred to the images from each of the other emission scans to obtain the time course of total radioactivity in each ROl . In addition, whole-brain radioactivity was deter mined as the weighted average of the radioactivity in the seven image planes. The plasma glucose concentration was relatively constant throughout each study; mean plasma glucose levels ranged from 0.83 to 0.89 mg/ml among the subjects.
Analysis of PET data
For each ROI, each of the spectral analysis program implementations, with either an unweighted or a weighted objective function and with the simplex algorithm, was executed for 28 subintervals of the interval of time be tween the administration of the tracer and the end of the PET scanning, 120 min later. The unweighted and weighted objective functions with the nonnegative least squares algorithm were also executed for selected regions and time intervals. The range and distribution of the ex ponents �. used in the analysis of the PET data were those found to be optimal in the simulation studies. The time intervals examined began 0, 15, 30, 45, 60, 75, or 90 min following the pulse of [18F]FDG and ended 30, 45, 60, 75, 90, 105, or 120 min later. For each ROJ and time interval, rCMRg1c was calculated according to Eq. (22), with the value of the lumped constant set at 0.52 as measured by Reivich et aI. (1985) . rCMRglc was also compared with values previously determined in the same subjects (Lu cignani et aI., 1993) with the three-rate constant model (3K model) (Reivich et aI., 1979 ; Sokoloff et aI., 1977) and by the multiple-time graphical analysis technique (Gjedde, 1982; Patlak et aI., 1983; Patlak and Blasberg, 1985) .
RESULTS

Implementation of the spectral analysis technique and simulation studies
Choice of algorithms. Differences between re sults obtained with the simplex and the nonnegative least-squares algorithms and between the un weighted and the weighted analyses were negligi ble. All results presented here were obtained with the simplex algorithm and an unweighted proce dure.
Exponents I3j. Figure 3 illustrates the results of the simulation studies used to determine the detect able components of the system. Data presented are for those studies in which the gray and white tissues were equally mass-weighted. Noise added to the stimulated tissue data led to detection of both low and high-frequency "phantom" components that were not present in the original data, The noise also led to a shift in the mean value of the exponent of slower component and to spreading of the distribu tions of the exponents of both equilibrating compo nents about their mean values. At high noise levels, it was difficult to separate the distributions of the two equilibrating components regardless of the rel ative gray/white tissue mass-weighting. At lower noise levels, two separate distributions were appar ent when the white matter represented either 50% of the total weight ( Fig. 3) or 80% of the total weight (data not shown). Even at low noise levels, two separate distributions are not readily discernible when the white matter represented only 20% of the total weight (data not shown). For the simulations that assumed equal mass weights for gray and white matter, the mean and standard deviation of the dis tributions of the exponent I3j for the simulated white matter were 0.16 ± 0.04, 0. 11 ± 0.04, and 0.09 ± 0.05 min -1 for the intervals 0--60, 0-90, and 0-120 min, respectively. The corresponding median val ues exponent were 0.09, 0.07, and 0.06 min -1 . In the simulated gray matter, the mean and standard deviation of the distributions of the exponent I3j were 0.55 ± 0,28, 0.55 ± 0.33, and 0.52 ± 0.25 min -1 for the scanning intervals of 0-60, 0-90, and 0-120 min, respectively. The median value for the gray matter exponent was 0.46 min -1 in all time intervals. The number of low-frequency compo nents that were detected even though they were not present in the simulated data decreased as the time of the final scan increased. The cutoff frequency below which components were indistinguishable from the integrated plasma component varied some what according to the noise level and the relative tissue weights and varied strongly according to the total length of time over which tissue radioactivity was measured, the longer the time of measurement, the smaller the cutoff frequency. For scanning in tervals of 60, 90, and 120 min, the cutoff frequencies were found to be 0.02, 0.01, and 0.008 min -1, re spectively, or �(1 /T) min -1 , where T is the end time of the scanning interval. The upper limit of the fast component distribution was �2 min -1 for these simulation studies in which the midpoint of the first scan was 0.5 min after tracer injection. Examination of the various distributions for the exponents I3j re vealed that the estimates of the coefficient of the integrated plasma activity, Ao, were most sensitive to the inclusion of slowly equilibrating components, i.e., those with small values of I3j• As expected, the estimates of Ao were completely insensitive to the Frequency distribution of compo nents identified in a simulated heteroge neous tissue comprised of a blood compart ment and two equally weighted tissue com partments (�j = 0.5 min -1 for gray matter and �j = 0.05 min -1 for white matter) for PET studies lasting either 60, 90, or 120 min. Normally distributed random noise with zero mean and standard deviation based on the counts found in each time interval following injection of tracer in a small white matter re gion (high noise; A) or in a whole image plane (low noise; 8) was added to the simu lated total radioactivity, and the spectral analysis program executed 1, 000 times. The total number of times (on the vertical axis) that a component with the exponent �j (on the horizontal axis) was found by the spec tral analysis program to have a nonzero co efficient is shown. Noise added to the data led to detection of both low-and high frequency components, i. e. , those with very small and very large values of the exponents �j, that were not present in the simulated tis sue; these are labeled "phantom compo nents." Noise in the data also led to a shift in the mean of the more slowly equilibrating component and to a spreading of the distri butions of both equilibrating components. The number of low-frequency phantom com ponents decreased as the time of the final scan increased. The cutoff frequency below which components were indistinguishable from the integrated plasma compartment is seen as the "trough" between the distribu tion of low-frequency noise and the distribu tion around the simulated white matter com ponent. The cutoff frequency was found to be approximately (1/T) min -1 , where T is the end time of the scanning interval. high frequencies, i.e., fast components, included in the spectrum. Therefore, we selected a distribution with good coverage of exponents in the low range; the distribution of exponents that we used was based on one suggested by DiStefano (1981) , where the fastest and slowest time constants were 0. 5 and 300 min, respectively, and the number of the points of the distribution was set at 100 [Eq. (28)].
Spectra identified in ROls in scanned subjects Figure 4 illustrates spectra identified in one sub ject from the total radioactivity measured over the interval beginning at the time of tracer injection and ending 30, 45, 60, 75, 90, 105, or 120 min later in three regions of interest: the frontal cortex, white matter, and whole brain. Four distinct components in the spectrum were identified: an integrated com ponent, a slowly equilibrating component, a more rapidly equilibrating component, and a blood com ponent ( Fig. 4A-C ; blood component not shown).
(Two adjacent components are considered here to be a single distinct component.) The coefficient of the blood component, A-I' ranged from 0. 01 to 0.08 13 j (lIntin) mllg. Similar patterns were observed in the spectra in most other regions of interest. For example, in the interval 0-120 min, 82 of the 90 gray matter regions examined had a component at 0 min -1, i.e., an integrated component. Of the eight regions that did not have an integrated component, all eight had peaks in the very low-frequency range that was shown in the simulation studies to be indistinguish able from an integrated component, i.e., 0.0033 min -1 < �j < 0.0083 min -1. Seventy-seven of the 90 gray matter regions had two or three equilibrat ing components that were clearly distinguishable from the integrated component, i.e., 0.0083 min -1 ,;;; �j < 2.0 min -1. In the same time interval (0-120 min) the fit of the data by an integrated component plus two equilibrating components was highly sta tistically significantly better than the fit of the data by an integrated component plus one equilibrating component in 84 of the 90 gray matter regions ex amined and in whole brain [p < 0.005, F test for comparison of nested models (Landaw and DiSte fano, 1984) ]. All solutions found by the spectral analysis program were unique, i.e., no other com- bination of components could be selected that would describe the measured data as well as those components that were chosen. In the relatively small white matter region (3.8 cm3), two equilibrat ing components were found (Fig. 4B ), although this fit was statistically significantly better than that with one equilibrating component in only two of the three subjects (p < 0.05). When total radioactivity data were analyzed over an interval beginning 15 or more min after tracer injection, the more rapidly equilibrating component was not detected, and in the intervals beginning either 75 or 90 min after tracer injection, neither the rapidly nor the slowly equilibrating component was detected ( Fig. 5A-C ; blood component not shown). The magnitude of the coefficient of the integrated plasma component, Ao, was relatively constant with the different intervals analyzed, except for the short time intervals that occurred immediately after tracer injection (e,g., 0-30 min) or those that occurred very late in the ex perimental period (e,g., 90-120 min). A summary of the distribution of the components detected in 90 gray matter regions for the intervals beginning at the time of tracer injection and ending 60, 90, or 120 min later is shown in Fig. 6 . In addition to the blood component (not shown) and the integrated plasma component, a bimodal distribution of equilibrating components was found, As had occurred in the sim ulation study, the number of very small components detected by the spectral analysis program de creased as the length of the scanning interval in creased. Figure 7 illustrates the effects of noise in the data on the spectrum derived from a representative re gion of interest. In the region shown, when the data were analyzed in the 0 to 60-min time interval, no very low-frequency components were found, i.e., those with 0.0033 min -I < I3j < 0.0167 min -I, and Ao = 0.043 ml g-I min -I (rCMRglc = 42IA-moi 100 g-1 min -I) . But in this region the total radioactivity measured at 70 and 75 min fell below the values that would be expected if the time-activity curve were smoothed or interpolated between 65 and 80 min ( Fig. 7 A) . When the data from 0 to 75 min were analyzed, the analytical procedure treated the lower values of total radioactivity as loss from the system and identified no integrated plasma component, i.e., Ao = 0.0 ml g -1 min -I, but found components with exponents of 0.0063 and 0.0067 min -I, i.e., a shift in the spectrum had occurred (Fig. 7B) . With out compensating for the noise and subsequent shift in the spectrum, the finding of a zero value for Ao would lead to a calculated rate of glucose utilization of 0 IA-mol 100 g -1 min -1. When the data from 0 to 90 min were analyzed, the value of Ao returned to approximately its previous level of 0.045 ml g-I min -I (rCMRglc = 43 IA-mol 100 g-I min -I).
Effects of noise in scanned data
Numerical filtering
As illustrated in Fig. 7 , very small components were often detected when the last time point or last few time points used in the analysis fell below the curve extrapolated from the previous points (Fig.  7A, dashed line) . In these cases the estimate of Ao was small or equal to zero and glucose utilization calculated from Ao was underestimated. Table 1 gives the rates of glucose utilization determined over the interval 0-90 min by each of three methods investigated for correcting the estimate of Ao in the presence of noise in 14 representative gray matter regions, in white matter, and in whole brain. A cut-off frequency of (1/1) min -I, as determined from the simulation studies, was used. Method 1, the ad dition of coefficients, led to the highest corrected estimates of Ao and, therefore, to the highest values of rCMRg1c-Method 2, the elimination of all com ponents below the cutoff frequency, led to the low est corrected estimates of Ao, whereas Method 3, the numerical filter, led to intermediate values. For comparison, Table 1 also lists the rCMRglc deter mined previously in the same subjects (Lucignani et aI., 1993) by the 3K model and by the multiple-time graphical analysis technique. In most regions of in terest, the numerically filtered data show the lowest variability and agree most closely with the rCMRglc determined by conventional methods.
Time-stability of calculated rates of glucose utilization
Glucose utilization in the frontal cortex, white matter, and whole brain calculated with the spectral analysis procedure from the total radioactivity mea sured over the various time intervals is shown in Fig. 8 . Except for the very early time intervals, i.e., those ending 30 min after tracer injection, and the very late time intervals, i.e., those beginning 90 min after tracer injection, when there are few data points, the calculated rCMRglc was fairly constant. Table 2 summarizes the rCMRglc determined in six of those time intervals in 14 representative gray matter regions, in white matter, and in whole brain.
DISCUSSION
The spectral analysis technique for the evaluation of kinetic PET data, introduced by Cunningham et al. (1991) , is a powerful tool for the detection of components in PET dynamic data. Whereas classi cal compartmental analyses have been based on the a priori definition of a kinetic model and nonlinear least-squares algorithms to estimate the parameters of the model, this new approach describes the mea sured data by selecting a linear combination of com ponents from a large set of potential components. The only requirement is to predefine the potential components, e.g., the convolution integrals arising from the solution of a general compartmental model, that can be used as the building blocks to describe the system. Since there is no need for fixed-structure models, this method may be helpful in designing new compartmental models as well as in evaluating the applicability of existing models to any system under observation. Although the com ponents found by spectral analysis do not depend on a specific model, however, the interpretation of the significance of each of those components can be derived only on the basis of some structural model. Frequency distribution of components identified in a total of 90 gray matter regions for PET studies lasting either 60, 90, or 120 min. The total number of times (on the vertical axis) that a component with the exponent i3j (on the hori zontal axis) was found to have a nonzero coef ficient by the spectral analysis program is shown. In addition to the blood component (not shown) and the integrated plasma component, a bimodal distribution of equilibrating compo nents was found. Even though nominally only gray matter regions were analyzed, the bimodal distribution of components is consistent with the inclusion of both gray and white matter tis sues. The very low-frequency components are probably due more to noise in the data than to real equilibrating processes since the number of such components decreases as the length of the scanning interval increases.
In the current study we have examined the prop erties of the spectral analysis technique by applying it to dynamic eSF]FDG data because there is al ready much known about the kinetic behavior of this tracer compound. In a homogeneous tissue the kinetics of eSF]FDG can be described by a three rate constant compartmental model (3K model) as long as the loss of eSF]FDG-6-P is negligible (Rei vich et aI., 1979) . According to the 3K model, the FIG. 7. Effect of noise in the data on the spectrum. Underestimation of the total radio activity in the intervals ending 70 or 75 min after tracer injection (A) led to a shift in the spectrum (8). An integrated plasma compo nent, but no very low-frequency compo nents, was found when data were analyzed over the intervals 0-60 and 0-90 min. When data from 0 to 75 min were analyzed, how ever, the analytical procedure treated the lower-than-expected values of total radioac tivity as loss from the system and identified components with exponents of 0.0063 and 0.0067 min-1 and no integrated plasma com ponent. Without compensating for the noise and subsequent underestimation of the co efficient of the integrated plasma compo nent, the calculated rate of glucose utiliza tion would be too low. time course of total radioactivity measured in a ho mogeneous tissue can be described as the sum of a term that represents the radioactivity in the blood in the tissue (a blood component), a term that repre sents the integrated arterial plasma activity (an in tegrated component), and a single term describing the equilibration of the tissue with the arterial plasma (an equilibrating component). If, however, the region of interest is comprised not of a single, homogeneous region, but rather of a heterogeneous mixture of kinetically distinct tissues, then two or more equilibrating components are required in ad dition to the integrated component. Two equilibrat ing components would also result from a homoge neous tissue from which there is a loss of metabolic product (Phelps et aI., 1979) , but such tissue would have no integrated component. The first goal of this work was to use the spectral analysis technique to establish the number of components necessary to describe the time course of total radioactivity mea sured in various brain regions following a pulse of [lsp]PDG. In most regions examined, when the data were evaluated from the time of tracer injection un til 30 or more min later, we found that it was nec essary to use at least two equilibrating components, in addition to the integrated component and a blood component, to describe the time course of total ra dioactivity. In some regions a very fast component (l3j = 2 min -I) was also required, probably due to dispersion or noise in the input function (Cunning ham and Jones, 1993) . The presence of at least two equilibrating components plus an integrated compo nent clearly indicates the presence of kinetic het erogeneity. Kinetic heterogeneity is consistent with previous findings. Por example, with the 3K model, estimates of the rate constants for efflux and for phosphorylation of eSp]PDG, k� and kj, respec tively, are expected to decline with time if the re gion of interest is heterogeneous (Schmidt et aI., 1991) , and with PET eSp]PDG data examined in previous studies, such declines were indeed ob-served in all regions of interest, regardless of their size (Schmidt et aI., 1992; Lucignani et aI., 1993) . Because the multiple-time graphical analysis technique (Gjedde, 1982; Patlak et aI., 1983; Patlak and Blasberg, 1985) applies equally well to hetero geneous and to homogeneous tissues (Mori et aI., 1990) , it has also been applied to kinetic PET eSp]PDG data to determine regional rates of glu cose utilization (Gjedde et aI., 1985) . This technique is based on the premise that following equilibration between tissue and plasma, the apparent distribu tion space of the tracer , plotted against the normal ized plasma integral of tracer, will increase linearly as long as there is no product loss. The slope of the linear portion of the graph is directly proportional to the rCMRg\c. Application of this technique requires the identification of a starting time after which all the tissue pools have equilibrated with the arterial plasma and an upper time limit before product loss occurs. Either lack of equilibration of any of the tissue pools in the region of interest with the arterial plasma or loss of metabolic products may cause downward curvature of the graph and a subsequent fall in calculated rates of glucose utilization as the ending time of the interval used in the analysis is increased. Lammertsma et aI. (1987) have observed falling calculated rates of glucose utilization as late as 38-50 min following the pulse of eSp]PDG, and we have observed downward curvature of the P,!-t lak plot in most ROIs in intervals that began before 45-60 min following the injection of tracer (Lucig nani et aI., 1993) . In our previous study the curva- ture of the plot actually reversed in later time inter vals in most regions of interest. We concluded , therefore, that early downward curvature was due to lack of equilibration of some of the tissue pools included in the ROI with the arterial plasma. In the current study when data were analyzed by spectral analysis over time intervals beginning after varying amounts of delay following tracer injection, slowly equilibrating components, e.g., those with 0.02 < �j < 0.1 min -1, were detected in most ROIs until the start time of the analysis interval exceeded 60 min. These findings support the conclusions of the ear lier studies that slowly equilibrating components are present for as long as 1 h following tracer injec tion.
The findings of this study also illustrate how noise in the data combined with the tissue data sam pling schedule affect the components that can be J Cereb Blood Flow Metab, Vol. 14, No . 3, 1994 detected by the spectral analysis technique. With the dynamic scanning protocol used in the current study the exponents of the rapidly equilibrating components could not be detected with great cer tainty, as shown by the high variance of the expo nent of the detected the gray matter component in the simulation data (Fig. 3 ). More precise identifi cation of rapidly equilibrating components would require more frequent sampling of the tissue data at early times. Also shown by the simulation study were very slowly equilibrating components that were detected even though they are not present in the original data, i.e., the low-frequency "phantom components" in Fig. 3 . The shorter the scanning schedule and the higher the noise level, the broader the distribution of low-frequency phantom compo nents (Fig. 3) . For example, even in the 0 to 120-min simulation study we found that components with exponents smaller than 0.008 min -1 could probably not be distinguished from the integrated compo nent when there are high noise levels in the tissue radioactivity data. For more precise identification of smaller components, either a reduction in the noise level or a longer scanning time would be nec essary.
Nonzero low-frequency components would also be expected if there is a loss of metabolic products (Phelps et aI., 1979) . The number of low-frequency components due to loss, however, would be ex pected to increase at later scanning times, whereas the number of low-frequency components that are due to noise decreases as the time of the last scan increases (Fig. 3) . In the actual PET data, the num ber of nonzero low-frequency components de creased as the scanning time increased (Fig. 6 ). Thus we can infer that the low-frequency compo nents are likely to be due more to noise than to significant loss of metabolic products. As shown in the simulation studies, the upper bound on the fre quency that can be distinguished from the inte grated component is approximately (lIn min -1, or approximately 0.008 min -I for l20-min studies; this represents an upper bound for the exponents of any components that may be due to loss of metabolic product as well. This finding is consistent with pre vious studies in which no evidence of significant product loss was found in the first 120 min following injection of [18F]FDG (Schmidt et aI., 1992; Lucig nani et aI., 1993) .
Noise in the radioactivity data is an unavoidable problem of measurement. Noise due to low count ing rates is a major problem in the very early data when uptake of the tracer is low and, also, in very late data due to radioactive decay of the isotope. For this reason, we investigated the possibility of weighting the objective functions that were to be minimized [Eqs. (23) and (25)] to take into account the uncertainty in the measured total radioactivity. Weighting the measured tissue data by its variance had no effect on the components detected or on the glucose utilization rate determined by the spectral analysis technique. However, as shown in Figs. 3 and 7, noise in the data can lead to the artefactual detection of very low frequency components, and the calculated rates of glucose utilization depend upon treatment of those components. When the co efficients of all the very low-frequency components were added to the coefficient of the integrated plasma activity, Ao, we found that the glucose uti lization rate was overestimated compared to rates determined by the 3K model and multiple-time graphical analysis when these methods were ap plied in a time interval late enough to minimize the effects of tissue heterogeneity and to allow the equilibration of all the tissue pools with the arterial plasma (Table 1) (Lucignani et aI., 1993) . The over estimation is to be expected if one notes the mono tonicity of the equilibrating components with re spect to the exponents 13/ at any given time, the higher the exponent I3j, the lower the value of the equilibrating component. Thus a lower-frequency component requires a higher coefficient to make a comparable contribution to the total radioactivity. The summation of the coefficients of the low frequency components that resulted from noise in the data would thus lead to an overestimation of the true Ao and an overestimation of the rate of glucose utilization. If the low-frequency components were indeed due to noise in the data, one might assume that eliminating them from the spectrum would re sult in correcting the estimate of the true Ao. When this strategy was used, however, the noisy data were modeled as the combination of a reduced in tegrated plasma component plus a component with the smallest available nonzero exponent, and the calculated glucose utilization was lower than that determined by the conventional methods (Table 1) . Some type of filtering of noisy data is required; the use of the numerical filter described under Materi als and Methods led to calculated rates of glucose utilization closest to those obtained by conventional methods.
To evaluate the stability of the method for esti mating rCMRglc, we applied spectral analysis to data collected over widely differing time intervals and found that the calculated rCMRglc was reason ably constant except when determined over very early time intervals, e.g., 0-30 min, or over very late intervals, e.g., those beginning 75 or 90 min after the injection of tracer. The values of rCMRglc and their variability determined by spectral analysis appeared to be comparable to those determined by the multiple-time graphical analysis when both techniques were applied in a time interval suffi ciently late that the tissue pools had equilibrated with the arterial plasma, e.g., 60-90 min after tracer injection. The spectral analysis technique, how ever, appears to be useful also in time intervals ear lier than those in which the graphical analysis should be applied because spectral analysis does not require the equilibration of the tissue pools. The lowest variability in rCMRglc was found in the val ues calculated by use of the 3K model and the sin-gle-scan procedure occurring >60 min following the injection of tracer; this method allowed the shortest time in the scanner as well (Lucignani et al ., 1993) . The variability in that study may have been some what lower than expected since the rate constants were determined in the same population to which they were later applied for calculation of rCMRglc; more variability could be expected if rate constants from a different population had been applied (Lu cignani et al., 1993) . The use of a dynamic scan with the 3K model and the determination of each sub ject's own rate constants has been shown to be a poor alternative to the single-scan procedure, as the dynamic procedure requires an extended scanning period of at least 60 min to minimize the effects of tissue heterogeneity and obtain reliable estimates of the kinetic rate constants (Lucignani et al ., 1993) . Since the spectral analysis technique obviates the need for the determination of rate constants, it may be of more use when rate constants in a given sub ject are expected to differ very significantly from the population averages.
The purpose of the current study was primarily to investigate the properties of the spectral analysis technique rather than to promote a novel method for the determination of rCMRg!c. We have applied the technique to [18F]FDG so that the results could be readily assessed. Spectral analysis has been found to be a highly flexible tool for the description of complex systems that can produce low-variance, time-stable estimates of physiological parameters when optimized for time interval of application, spectrum of components, and processing of noise in the data. The results have also reinforced the un derstanding that ROI data acquired by PET scan ning contain a kinetically heterogeneous mixture of tissues, and the effects of the tissue heterogeneity on the determination of the function or process of interest must be taken into consideration when in terpreting the results of any study. Because the spectral analysis technique applies to heteroge neous as well as to homogeneous tissues, it may be useful in developing kinetic models and interpreting kinetic data for a wide range of tracer compounds in brain and other organs. 
